Novel tool uncovers new cell types in the visual system of flies

Cat­a­lyst Phar­ma­ceu­ti­cals’ con­tro­ver­sial $375,000 rare au­toim­mune dis­ease drug now won’t face gener­ic com­pe­ti­tion from Te­va un­til Feb. 25, 2035, thanks to a patent set­tle­ment an­nounced

More than 200 med­i­cines at risk of short­ages in the EU have been list­ed as crit­i­cal by the Eu­ro­pean Com­mis­sion, the Heads of Med­i­cines Agen­cies